Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

NCT01840306 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT01840306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Observational
Overall status
Completed
Start date
October 12, 2012
Completion date
May 24, 2023
Enrollment
330 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, her2 negative breast cancer, her2 positive breast cancer